Core Viewpoint - FOXO Technologies Inc. is holding a special shareholder meeting on January 17, 2025, to seek approval for several proposals related to acquisition transactions [1][2]. Group 1: Shareholder Meeting Details - The special meeting will take place virtually at 10:30 a.m. EST, and shareholders of record as of January 3, 2025, are entitled to vote [2]. - The main proposal involves the issuance of shares of Class A Common Stock related to the Series A Cumulative Convertible Redeemable Preferred Stock [8]. Group 2: Company Overview - FOXO operates three subsidiaries: Foxo Labs, Inc., which focuses on biotechnology and health solutions; Myrtle Recovery Centers, Inc., a behavioral health facility; and Rennova Community Health, Inc., which operates a critical access hospital [5][6]. Group 3: Executive Statement - The CEO of FOXO expressed the importance of shareholder support for the proposals to focus on revenue growth and potential acquisition opportunities post-meeting [4]. Group 4: Proposals for Approval - The proposals include: 1. Approval for the issuance of shares of Class A Common Stock upon conversion of Series A Preferred Stock [8]. 2. Approval for the adjournment of the meeting if necessary to solicit additional proxies [8]. 3. Consideration of other matters that may arise during the meeting [8].
FOXO TECHNOLOGIES INC.'S BOARD OF DIRECTORS ANNOUNCES SPECIAL MEETING OF SHAREHOLDERS